COVID-19 vaccination: Over 7.06 crore people inoculated so far, says Centre

-

New Delhi: The cumulative number of coronavirus vaccine doses administered in the country crossed seven crore with 12,76,191 doses given till 8 pm on Friday, the health ministry said as India registered this year's highest single day rise of 81,466 infections.

So far, 1,23,03,131 people have tested positive for coronavirus in the country, according to a provisional report till 7 pm on Friday.

The country has administered a total of 7,06,18,026 vaccine doses till 8 pm, the ministry said, adding that the number included 6,13,56,345 people who received its first dose.

The second dose of the vaccine has been administered to 92,61,681 people. The ministry said the numbers included 89,03,809 healthcare workers (HCWs) and 95,15,410 frontline workers, who have taken the first dose.

As many as 52,86,132 HCWs and 39,75,549 FLWs have taken the second dose, the ministry said, adding that 4,29,37,126 beneficiaries above 45 years of age been administered the first dose.

"Total 12,76,191 vaccine doses were given till 8 pm on Friday, the 77th day of nationwide COVID-19 vaccination, the ministry said, adding that 12,40,764 received the first dose while 35,427 beneficiaries got the second dose as per the provisional report and final numbers will be compiled by by late night.

A total of 11,83,917 people aged 45 and above were given the first dose on 2 April.

More than 36.7 lakh COVID-19 vaccine doses were administered on 1 April, the highest single-day coverage till now, the ministry had said.

The countrywide vaccination drive was rolled out on 16 January with healthcare workers getting inoculated and vaccination of frontline workers started from 2 February.

The next phase of COVID-19 vaccination commenced from 1 March for those over 60 years of age and for people aged 45 and above with specified co-morbid conditions.

India launched vaccination for all people aged 45 and above from 1 April.



from Firstpost India Latest News https://ift.tt/3fCp1Q9
Press Trust of India

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

120 flights delayed, 30 trains running late; Delhi fog & cold wave continue to give shiver to travellers

-
Arrival and departure of 120 flights, both domestic and international, to Delhi airport were affected due to dense fog and cold wave conditions on Wednesday, according to Delhi Airport FIDS (Flight Information Display System). As per the Delhi Airport FIDS, a total of 53 flights, including 21 domestic arrivals, 16 domestic departures, 13 international departures and three international arrivals scheduled are cancelled and not operating due to fog and other operational reasons from and to Indira Gandhi International (IGI) Airport in the national capital on 17 January. #WATCH | Delhi: Several flight operations delayed at IGI airport due to low visibility amid fog. pic.twitter.com/hG1DUKllEt — ANI (@ANI) January 17, 2024 Visuals from the Delhi airport showed passengers waiting outside, checking update of their scheduled flights. There were also some people waiting for flight of their families, friends and loved ones to arrive, which got delayed due to fog. #WATCH | Delhi | Pas
Read more